Compare · Healthcare · IQVIA
ParseData vs IQVIA
IQVIA and ParseData both sell lead data, but they are built on different foundations. Here is an honest read on where each fits — including where IQVIA is genuinely stronger.
At a glance
Side by side
| IQVIA | ParseData | |
|---|---|---|
| Category | Life-sciences data & analytics | Cross-industry buying-signal lead data |
| Pricing | ~$50k start, $200k+ multi-product, into $M for large pharma | $99–$599/mo, self-serve, transparent |
| Data spine | NPI / Open Payments (in OneKey) + massive proprietary licensed Rx/claims | Official records as dated, first-class Parse events |
| Model | Sales-led / quote-gated | Parse-first, self-serve |
What they do
IQVIA
OneKey reference (25M+ HCPs), Rx data (~90% of US retail) and adjudicated claims across 174M+ lives — the enterprise standard for pharma commercial and market analytics.
Source: www.iqvia.com. Pricing per the competitive-landscape research (public pages + third-party estimates).
Where ParseData differs
ParseData's edge
- Self-serve access to the NPI / affiliation / Open-Payments layer for SMB and long-tail buyers IQVIA won't quote.
- Parse-first provider-change events instead of enterprise reference feeds.
- Cross-industry breadth at a self-serve price.
Where they're stronger
IQVIA's edge
- Rx, adjudicated claims and global coverage are untouchable — ParseData does not compete there.
The honest read
IQVIA is the enterprise Rx/claims standard. ParseData only steals the cheap, self-serve provider/Open-Payments buyer they overprice.
Comparison is observational and based on public information as cited; vendor names and trademarks belong to their owners. ParseData serves sanitized public US federal records — not a consumer report, no FCRA use.